Standout Papers
Citation Impact
Citing Papers
Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
2014
Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer
2007
Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers
2007
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Intensity-Modulated Radiotherapy of Head and Neck Cancer Aiming to Reduce Dysphagia: Early Dose–Effect Relationships for the Swallowing Structures
2007
Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements
2013
The role of laser microsurgery in the treatment of laryngeal cancer
2007
Current clinical outcomes demand new treatment options for SCCHN
2005
Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up
2004
Expanding global access to radiotherapy
2015 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Second non-germ cell malignancies in patients treated for stage I–II testicular seminoma
1999
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
2008
Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study
2011
Drug penetration in solid tumours
2006 Standout
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
2006
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Current concepts and new horizons in conservation laryngeal surgery: An important part of multidisciplinary care
2009
How to reduce radiation-related toxicity in patients with cancer of the head and neck
2006
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
2004
Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
2008
Nasopharyngeal carcinoma
2019 Standout
68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives
2011
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
The molecular biology of head and neck cancer
2010 Standout
Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment
2008
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
2005
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion
2009
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
2005
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Radiation Therapy–Related Toxicity (Including Pneumonitis and Fibrosis)
2009
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?
2008
Targeting apoptosis in cancer therapy
2020 Standout
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma
2018
Nasopharyngeal carcinoma
2015 Standout
The chemoradiation paradigm in head and neck cancer
2007
MicroRNA biogenesis pathways in cancer
2015 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
State-of-the-art management of locally advanced head and neck cancer
2005
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
TGFβ in Cancer
2008 Standout
Testing treatment effects in the presence of competing risks
2005
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Intensity-modulated radiation therapy in head and neck cancers:The Mallinckrodt experience
2000
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
The molecular landscape of head and neck cancer
2018 Standout
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
2007
The Hippo pathway and human cancer
2013
Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula
2008
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
CERR: A computational environment for radiotherapy research
2003
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
Endometrial cancer
1997
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
2013
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Extended Lateral Pharyngotomy for Selected Squamous Cell Carcinomas of the Lateral Tongue Base
2009
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
2008
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
2020
Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?
2006
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
2012
Head and Neck Cancer
2020 Standout
Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy
2005
The relationship between inflammation and cancer is analogous to that between fuel and fire.
2011
Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?
2005
Long‐Term Quality of Life After Total Laryngectomy and Postoperative Radiotherapy Versus Concurrent Chemoradiotherapy for Laryngeal Preservation
2008
Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
2006
Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
2004
Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review
2008
Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
2011
Review of image-guided radiation therapy
2006
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
2005
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1
2019
Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era
2010
Increased NBS1 Expression Is a Marker of Aggressive Head and Neck Cancer and Overexpression of NBS1 Contributes to Transformation
2006
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN)
2016
Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
2004
Mortality After Cure of Testicular Seminoma
2004
Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum
2006
Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
2014
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes
2015
Rattle-Structured Multifunctional Nanotheranostics for Synergetic Chemo-/Radiotherapy and Simultaneous Magnetic/Luminescent Dual-Mode Imaging
2013
Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy
2019
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2017
Predictors of Competing Mortality in Advanced Head and Neck Cancer
2009
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018
Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
2005
Works of C. Chao being referenced
Reirradiation of recurrent skin cancer of the face. A successful salvage modality
1995
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)
2009
Analysis of Treatment Results for Base of Tongue Cancer
2003
Secondary malignancy among seminoma patients treated with adjuvant radiation therapy
1995
Analysis of Treatment Results for Oral Tongue Cancer
2002
Infrared-based module for the synthesis of 68Ga-labeled radiotracers
2007
Management of Radiation-Induced Head and Neck Injury
2006
Brachytherapy-related complications for medically inoperable Stage I endometrial carcinoma
1995
Cyclin D1 Guanine/Adenine 870 Polymorphism With Altered Protein Expression Is Associated With Genomic Instability and Aggressive Clinical Biology of Esophageal Adenocarcinoma
2007
Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma
2006
Recovery kinetics of salivary function in patients with head and neck cancers receiving radiation therapy
2002
Radiation-induced anatomic changes during fractionated head & neck radiotherapy: a pilot study using an integrated CT-LINAC system
2003